Skip to main content
Erschienen in: Lung 2/2009

01.04.2009

HLA Antigens and Nontuberculous Mycobacterial Lung Disease in Korean Patients

verfasst von: Sang-Won Um, Chang-Seok Ki, O Jung Kwon, Won-Jung Koh

Erschienen in: Lung | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Human leukocyte antigen (HLA) molecules are known to play an important role in host-defense mechanisms. The aim of this study was to evaluate the association between HLA alleles and lung disease caused by nontuberculous mycobacteria (NTM) in Korean patients.

Methods

Seventy-eight patients with NTM lung disease (48 patients with Mycobacterium avium-intracellulare complex [MAC] infection and 30 patients with Mycobacterium abscessus infection) were included in the study. HLA-A, -B, and -DRB1 genotyping was performed by polymerase chain reaction using sequence-specific primers. Data from 485 healthy Korean individuals were used as a control.

Results

When compared to controls, patients with NTM lung disease showed an increased frequency of DRB1*11 (OR = 1.91, 95% confidence interval [CI] = 1.01–3.64, p = 0.045, corrected p [pC] > 0.05). In the subgroup analysis, patients with MAC lung disease had an increased frequency of B*46 (OR = 2.23, 95% CI = 1.05–4.73, p = 0.044, pC > 0.05).

Conclusions

Our data suggest that in a Korean population, patients with NTM lung disease and healthy subjects differ in the frequencies of some HLA alleles. However, when considering corrected p values, our findings are inconclusive.
Literatur
1.
Zurück zum Zitat Wallace RJ Jr, Cook JL, Glassroth J, Griffith DE, Olivier KN, Gordin F (1997) American Thoracic Society statement: diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156:S1–S25 Wallace RJ Jr, Cook JL, Glassroth J, Griffith DE, Olivier KN, Gordin F (1997) American Thoracic Society statement: diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156:S1–S25
2.
Zurück zum Zitat Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K (2007) ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416PubMedCrossRef Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K (2007) ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416PubMedCrossRef
3.
Zurück zum Zitat Koh WJ, Kwon OJ, Lee KS (2005) Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective. J Korean Med Sci 20:913–925PubMedCrossRef Koh WJ, Kwon OJ, Lee KS (2005) Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective. J Korean Med Sci 20:913–925PubMedCrossRef
4.
Zurück zum Zitat Guide SV, Holland SM (2002) Host susceptibility factors in mycobacterial infection. Genetics and body morphotype. Infect Dis Clin North Am 16:163–186PubMedCrossRef Guide SV, Holland SM (2002) Host susceptibility factors in mycobacterial infection. Genetics and body morphotype. Infect Dis Clin North Am 16:163–186PubMedCrossRef
5.
Zurück zum Zitat Sexton P, Harrison AC (2008) Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 31:1322–1333PubMedCrossRef Sexton P, Harrison AC (2008) Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 31:1322–1333PubMedCrossRef
6.
Zurück zum Zitat Koh WJ, Kwon OJ, Kim EJ, Lee KS, Ki CS, Kim JW (2005) NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 128:94–101PubMedCrossRef Koh WJ, Kwon OJ, Kim EJ, Lee KS, Ki CS, Kim JW (2005) NRAMP1 gene polymorphism and susceptibility to nontuberculous mycobacterial lung diseases. Chest 128:94–101PubMedCrossRef
7.
Zurück zum Zitat Mai HN, Hijikata M, Inoue Y, Suzuki K, Sakatani M, Okada M, Kimura K, Kobayashi N, Toyota E, Kudo K, Nagai H, Kurashima A, Kajiki A, Oketani N, Hayakawa H, Tanaka G, Shojima J, Matsushita I, Sakurada S, Tokunaga K, Keicho N (2007) Pulmonary Mycobacterium avium complex infection associated with the IVS8–T5 allele of the CFTR gene. Int J Tuberc Lung Dis 11:808–813PubMed Mai HN, Hijikata M, Inoue Y, Suzuki K, Sakatani M, Okada M, Kimura K, Kobayashi N, Toyota E, Kudo K, Nagai H, Kurashima A, Kajiki A, Oketani N, Hayakawa H, Tanaka G, Shojima J, Matsushita I, Sakurada S, Tokunaga K, Keicho N (2007) Pulmonary Mycobacterium avium complex infection associated with the IVS8–T5 allele of the CFTR gene. Int J Tuberc Lung Dis 11:808–813PubMed
8.
Zurück zum Zitat Choo SY (2007) The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med J 48:11–23PubMedCrossRef Choo SY (2007) The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med J 48:11–23PubMedCrossRef
9.
Zurück zum Zitat Takahashi M, Ishizaka A, Nakamura H, Kobayashi K, Nakamura M, Namiki M, Sekita T, Okajima S (2000) Specific HLA in pulmonary MAC infection in a Japanese population. Am J Respir Crit Care Med 162:316–318PubMed Takahashi M, Ishizaka A, Nakamura H, Kobayashi K, Nakamura M, Namiki M, Sekita T, Okajima S (2000) Specific HLA in pulmonary MAC infection in a Japanese population. Am J Respir Crit Care Med 162:316–318PubMed
10.
Zurück zum Zitat Kubo K, Yamazaki Y, Hanaoka M, Nomura H, Fujimoto K, Honda T, Ota M, Kamijou Y (2000) Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection. Am J Respir Crit Care Med 161:1368–1371PubMed Kubo K, Yamazaki Y, Hanaoka M, Nomura H, Fujimoto K, Honda T, Ota M, Kamijou Y (2000) Analysis of HLA antigens in Mycobacterium avium-intracellulare pulmonary infection. Am J Respir Crit Care Med 161:1368–1371PubMed
11.
Zurück zum Zitat Lee KW, Oh DH, Lee C, Yang SY (2005) Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 65:437–447PubMedCrossRef Lee KW, Oh DH, Lee C, Yang SY (2005) Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens 65:437–447PubMedCrossRef
12.
Zurück zum Zitat Grotzke JE, Lewinsohn DM (2005) Role of CD8 + T lymphocytes in control of Mycobacterium tuberculosis infection. Microbes Infect 7:776–788PubMed Grotzke JE, Lewinsohn DM (2005) Role of CD8 + T lymphocytes in control of Mycobacterium tuberculosis infection. Microbes Infect 7:776–788PubMed
13.
Zurück zum Zitat Watts C (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15:821–850PubMedCrossRef Watts C (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15:821–850PubMedCrossRef
14.
Zurück zum Zitat Denis O, Stroobant V, Colau D, D’Souza S, Huygen K (2002) Culture filtrate specific H–2(b) restricted CD8 + T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptides. Immunol Lett 81:115–124PubMedCrossRef Denis O, Stroobant V, Colau D, D’Souza S, Huygen K (2002) Culture filtrate specific H–2(b) restricted CD8 + T cells activated in vivo by Mycobacterium tuberculosis or bovis BCG recognize a restricted number of immunodominant peptides. Immunol Lett 81:115–124PubMedCrossRef
15.
Zurück zum Zitat Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV, Boom WH (1999) Activation of human CD8 + alpha beta TCR + cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immunol 162:372–379PubMed Canaday DH, Ziebold C, Noss EH, Chervenak KA, Harding CV, Boom WH (1999) Activation of human CD8 + alpha beta TCR + cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway. J Immunol 162:372–379PubMed
16.
Zurück zum Zitat Lewinsohn DM, Grotzke JE, Heinzel AS, Zhu L, Ovendale PJ, Johnson M, Alderson MR (2006) Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathway. J Immunol 177:437–442PubMed Lewinsohn DM, Grotzke JE, Heinzel AS, Zhu L, Ovendale PJ, Johnson M, Alderson MR (2006) Secreted proteins from Mycobacterium tuberculosis gain access to the cytosolic MHC class-I antigen-processing pathway. J Immunol 177:437–442PubMed
17.
Zurück zum Zitat Kettaneh A, Seng L, Tiev KP, Toledano C, Fabre B, Cabane J (2006) Human leukocyte antigens and susceptibility to tuberculosis: a meta-analysis of case-control studies. Int J Tuberc Lung Dis 10:717–725PubMed Kettaneh A, Seng L, Tiev KP, Toledano C, Fabre B, Cabane J (2006) Human leukocyte antigens and susceptibility to tuberculosis: a meta-analysis of case-control studies. Int J Tuberc Lung Dis 10:717–725PubMed
18.
Zurück zum Zitat Rajalingam R, Mehra NK, Jain RC, Myneedu VP, Pande JN (1996) Polymerase chain reaction–based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. J Infect Dis 173:669–676PubMed Rajalingam R, Mehra NK, Jain RC, Myneedu VP, Pande JN (1996) Polymerase chain reaction–based sequence-specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. J Infect Dis 173:669–676PubMed
19.
Zurück zum Zitat Teran-Escandon D, Teran-Ortiz L, Camarena-Olvera A, González-Avila G, Vaca-Marín MA, Granados J, Selman M (1999) Human leukocyte antigen-associated susceptibility to pulmonary tuberculosis: molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients. Chest 115:428–433PubMedCrossRef Teran-Escandon D, Teran-Ortiz L, Camarena-Olvera A, González-Avila G, Vaca-Marín MA, Granados J, Selman M (1999) Human leukocyte antigen-associated susceptibility to pulmonary tuberculosis: molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients. Chest 115:428–433PubMedCrossRef
20.
Zurück zum Zitat LeBlanc SB, Naik EG, Jacobson L, Kaslow RA (2000) Association of DRB1*1501 with disseminated Mycobacterium avium complex infection in North American AIDS patients. Tissue Antigens 55:17–23PubMedCrossRef LeBlanc SB, Naik EG, Jacobson L, Kaslow RA (2000) Association of DRB1*1501 with disseminated Mycobacterium avium complex infection in North American AIDS patients. Tissue Antigens 55:17–23PubMedCrossRef
21.
Zurück zum Zitat Naik E, LeBlanc S, Tang J, Jacobson LP, Kaslow RA (2003) The complexity of HLA class II (DRB1, DQB1, DM) associations with disseminated Mycobacterium avium complex infection among HIV–1-seropositive whites. J Acquir Immune Defic Syndr 33:140–145PubMedCrossRef Naik E, LeBlanc S, Tang J, Jacobson LP, Kaslow RA (2003) The complexity of HLA class II (DRB1, DQB1, DM) associations with disseminated Mycobacterium avium complex infection among HIV–1-seropositive whites. J Acquir Immune Defic Syndr 33:140–145PubMedCrossRef
22.
Zurück zum Zitat Douby DP (1992) Quantitative aspects of HLA. In: Rose NR, Conway de Macario E, Fahey JL, Friedman H, Penn GM (eds) Manual of clinical laboratory immunology, 4th edn. American Society for Microbiology, Washington, DC Douby DP (1992) Quantitative aspects of HLA. In: Rose NR, Conway de Macario E, Fahey JL, Friedman H, Penn GM (eds) Manual of clinical laboratory immunology, 4th edn. American Society for Microbiology, Washington, DC
23.
Metadaten
Titel
HLA Antigens and Nontuberculous Mycobacterial Lung Disease in Korean Patients
verfasst von
Sang-Won Um
Chang-Seok Ki
O Jung Kwon
Won-Jung Koh
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
Lung / Ausgabe 2/2009
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-009-9136-8

Weitere Artikel der Ausgabe 2/2009

Lung 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.